MAT Clinics in Denver: Buprenorphine, Methadone, and Naltrexone Explained

Medication-assisted treatment is the most evidence-backed approach available for opioid use disorder, and Denver has a reasonable number of places to access it — but finding the right clinic, the right medication, and a provider who will actually work with you takes more effort than it should. If you’re trying to figure out the difference between buprenorphine, methadone, and naltrexone, or which Denver MAT clinic to call first, this is the breakdown you need.

What is medication-assisted treatment (MAT) and how does it work?

Medication-assisted treatment combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders — primarily opioid use disorder (OUD) and alcohol use disorder (AUD). The medications don’t replace therapy; they address the neurological dimension of addiction that therapy alone can’t reach.

The core mechanism differs by drug. Methadone and buprenorphine are opioid agonists — they bind to the same brain receptors as heroin or prescription opioids, reducing cravings and withdrawal without producing a significant high at therapeutic doses. Naltrexone is an opioid antagonist — it blocks those receptors entirely, so opioids have no effect. Three different mechanisms, three different clinical profiles, three different types of patients who do best on each.

Abundant evidence shows that methadone, buprenorphine, and naltrexone all reduce opioid use and OUD-related symptoms, and they reduce the risk of infectious disease transmission as well as criminal behavior associated with drug use. They also increase the likelihood someone stays in treatment — which is itself one of the strongest predictors of long-term recovery.

Is MAT the same as just replacing one drug with another?

This is the most persistent misconception in the field, and it’s genuinely damaging. It discourages people from accessing treatment that could save their lives, and it often comes from people who’ve never worked a day in addiction medicine. MAT stabilizes brain chemistry, reduces overdose risk, and creates the conditions where real therapeutic work can happen. Medication-assisted treatment does not cure opioid addiction. It treats it — the same way medications treat other chronic conditions like diabetes. No one calls insulin “replacing one drug with another.”

What is buprenorphine and where can I get it in Denver?

Buprenorphine — most commonly prescribed as Suboxone, the buprenorphine/naloxone combination — is the most accessible of the three MAT medications. Since the federal government eliminated the X-waiver requirement in 2023, any licensed prescriber can prescribe it. That’s a meaningful shift. Prior to that change, buprenorphine access was gated behind a specialized federal waiver, and the provider shortage was significant.

On average, someone dies in Colorado from an opioid-related overdose every 15 hours. Expanding buprenorphine access is one of the most direct levers Colorado has for reducing that number.

In Denver, buprenorphine is available through primary care offices, addiction medicine specialists, federally qualified health centers (like Denver Health), and standalone MAT clinics. Telehealth buprenorphine initiation is also now widely available and has shown strong retention outcomes — which matters enormously for a population where getting to a clinic is often the barrier.

What is Suboxone and how is it different from buprenorphine alone?

Suboxone combines buprenorphine with naloxone. The naloxone component is there to deter misuse — if the film is injected rather than dissolved under the tongue, the naloxone becomes active and precipitates withdrawal. It doesn’t affect therapeutic use. Most people prescribed buprenorphine in outpatient settings are on the buprenorphine/naloxone combination for exactly this reason.

How long do people stay on buprenorphine?

Longer than most people expect, and that’s clinically appropriate. Research consistently shows that stopping buprenorphine too early dramatically increases relapse and overdose risk. There is no evidence-based timeline that applies universally. Some people are on it for a year; some for many years. Duration should be a clinical decision made between the patient and prescriber — not driven by stigma, insurance pressure, or a program’s arbitrary taper schedule.

What is methadone treatment, and how does it work in Denver?

Methadone is the longest-standing MAT medication, used for opioid use disorder treatment since 1947. It’s also the most regulated. Unlike buprenorphine, methadone for OUD can only be dispensed through federally licensed opioid treatment programs (OTPs) — commonly called methadone clinics. Patients typically go daily, at least initially, to receive their dose under supervision.

That requirement is a real logistical burden. If you’re in early recovery without a car, work a 7am shift, or have childcare obligations, daily clinic visits are genuinely difficult to maintain. I’ve seen this barrier cause people to drop out of the most clinically appropriate treatment for them. It’s one of the most solvable access problems in addiction medicine and one of the least addressed.

Growing evidence suggests that methadone is as safe and effective as buprenorphine for patients who use fentanyl — a finding that matters a great deal in 2026, when fentanyl dominates the illicit opioid supply. SAMHSA’s 2024 regulatory changes to 42 CFR Part 8 were a step forward, expanding take-home dose flexibility and telehealth options for stable methadone patients. Denver Health operates one of the primary OTPs in the metro area and has been a hub in Colorado’s hub-and-spoke opioid treatment model.

Who is methadone most appropriate for?

People with severe, long-standing opioid use disorder who have tried buprenorphine and not responded, those with high-dose opioid tolerance (increasingly common with fentanyl use), and patients who benefit from the structure and accountability of daily clinic attendance. It’s not the right fit for everyone — but for the patients it’s right for, it’s often the most effective option available.

What is naltrexone and how is it different from the other MAT medications?

Naltrexone is a full opioid antagonist — it blocks opioid receptors without producing any opioid effect. It’s FDA-approved for both opioid use disorder and alcohol use disorder, which makes it one of the only MAT options relevant for both. The extended-release injectable form, sold as Vivitrol, is administered once monthly and has largely replaced daily oral naltrexone in clinical practice.

The key clinical consideration: naltrexone requires complete opioid detoxification before initiation. Typically seven to fourteen days opioid-free, depending on the opioid involved. Starting it before that window causes precipitated withdrawal — sudden, severe, and avoidable. This is the primary reason naltrexone doesn’t work as a first-line option for many people still in active opioid use: getting through that bridge to initiation is a genuine clinical challenge.

A 2024 NIDA-funded study found that a faster five-to-seven-day approach to naltrexone initiation resulted in significantly more patients successfully receiving their first XR-naltrexone injection compared to the standard seven-to-fifteen-day procedure (62.7% versus 35.8%). That’s a meaningful clinical development — the initiation barrier has been one of naltrexone’s biggest real-world limitations.

Is naltrexone a good option for alcohol use disorder?

Yes, and it’s underused in this context. Naltrexone for AUD doesn’t require the same opioid-free window (there’s no equivalent withdrawal risk), and the monthly injectable form removes the adherence problem that plagued oral naltrexone. For people with alcohol use disorder who aren’t also dealing with opioid dependence, Vivitrol is worth a specific conversation with a prescriber.

How do I choose between buprenorphine, methadone, and naltrexone?

Honestly, this isn’t a decision you should be making alone based on an article. A prescriber familiar with your use history, health status, and prior treatment attempts is the right person to lead that conversation. That said, here’s how the clinical picture generally sorts:

Buprenorphine tends to be the default starting point for opioid use disorder — accessible, effective, manageable in an outpatient setting, and now prescribable by any licensed provider. Most people with OUD are candidates.

Methadone is typically considered when buprenorphine hasn’t worked, when someone has very high opioid tolerance (common with fentanyl), or when daily structure and supervised dosing is actually a therapeutic benefit rather than a burden.

Naltrexone works best for people who are already opioid-free and highly motivated to remain so, or for those whose primary concern is alcohol use disorder. The initiation hurdle is real, and programs that don’t actively support patients through the detox-to-induction bridge see high dropout rates before the medication ever starts.

In 2022, an estimated 9.4 million U.S. adults needed treatment for opioid use disorder, but only one in four — 25.1% — received evidence-based MAT, according to the CDC. The gap isn’t about medication options; it’s about access, stigma, and the friction built into the system. Denver has more access points than most Colorado cities, but gaps remain — especially for uninsured and underinsured patients.

Does insurance cover MAT in Denver?

Most commercial plans cover at least one form of MAT, and Health First Colorado (Medicaid) covers all three FDA-approved medications for OUD. The Mental Health Parity and Addiction Equity Act requires insurers to cover substance use disorder treatment on par with medical care — in principle. In practice, prior authorizations, step therapy requirements, and coverage limits still create friction.

A Colorado pilot MAT program documented that after six months of treatment, participants reported reduced opioid, heroin, and alcohol use, along with better physical and mental health, with symptoms of depression, anxiety, and pain all decreasing — which makes the insurance access barriers even harder to justify clinically. Call the MAT clinic directly and ask them to verify your specific benefits. Most established programs have someone on staff who handles insurance verification before your first appointment.

Frequently asked questions

Is MAT available in Denver without insurance?

Yes, though options are narrower. Denver Health’s federally qualified health center operates on a sliding-scale fee structure and accepts uninsured patients. SAMHSA’s treatment locator at findtreatment.gov allows you to filter for programs that offer sliding-scale or free services. Some OTPs also have grant funding that covers a limited number of uninsured patients — worth asking directly.

Can I start buprenorphine through telehealth in Denver?

Yes. Since the federal X-waiver requirement was eliminated in 2023, telehealth buprenorphine initiation has expanded significantly. Several platforms — including those integrated with community health systems — can initiate buprenorphine treatment via video visit. Research published in JAMA Network Open (2023) found that telemedicine buprenorphine initiation was associated with strong treatment retention among Medicaid enrollees, which is an important finding for access.

What is precipitated withdrawal and how do I avoid it?

Precipitated withdrawal happens when naltrexone or buprenorphine is taken before other opioids have fully cleared the receptors — causing sudden, severe withdrawal. With buprenorphine, the risk is highest in the first dose if someone has used fentanyl recently, since fentanyl stays bound to receptors longer than shorter-acting opioids. A prescriber should walk you through timing carefully before your first dose. This is not something to guess at.

How is MAT different from medical detox?

Medical detox manages acute withdrawal — typically over three to seven days — and gets someone through the physical crisis of stopping opioids. MAT is an ongoing treatment approach that continues well beyond detox. Detox alone, without follow-up treatment, has very poor long-term outcomes. MAT is what happens after detox stabilizes the acute phase.

Can someone be on MAT and attend an outpatient program at the same time?

Yes, and this is the recommended approach. MAT addresses the neurological component of OUD; outpatient programming addresses the psychological, behavioral, and social dimensions. Programs like PHP and IOP at Denver treatment centers routinely work with clients who are on buprenorphine or naltrexone prescribed by a separate provider. The two treatments are designed to complement each other, not compete.

Continuing care and counseling alongside MAT in Denver

MAT medications are one component of a complete treatment approach — not a standalone fix. The research base consistently shows that medication plus counseling produces better outcomes than medication alone. This is where outpatient treatment programs become a critical part of the picture.

True North Recovery Services in Denver works with clients who are on MAT prescribed by their physician or an OTP, providing the behavioral health layer that makes medication effective over time. Our programs — including PHP, Active IOP, Trailhead IOP, and standard outpatient — address co-occurring mental health conditions alongside addiction, using evidence-based therapy modalities including CBT, DBT, somatic therapy, and narrative therapy. If you’re stabilized on buprenorphine or Vivitrol and need structured clinical support to build a recovery alongside it, that’s exactly the kind of program worth pursuing.

Same-day admits are available and the team is reachable seven days a week at (720) 271-3639. You can also reach out through the admissions page if a call feels like too much right now.